1KIEGER J, ALEXANDER A, FARACH-CARSON M C. Type I collagen-mediated changes in gene expression and function of prostate cancer cells[J]. Cancer Treat Res, 2004, 118: 101-124.
2KIEFER J A, FARACH-CARSON M C. Type I collagenmediated proliferation of PC3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment [J]. Matrix Biol, 2001,20(7) : 429-437.
3DAHLMAN T, LAMMERTS E, BERGSTROM D, et al. Collagen type I expression in experimental anaplastic thyroid carcinoma: regulation and relevance for tumorigenicity[J]. Int J Cancer, 2002,98(2) : 186-192.
4SENGUPTA P K, SMITH E M, KIM K, et al. DNA hypermethylation near the transcription start site of collagen alpha2 ( I ) gene occurs in both cancer cell lines and primary colorectal cancers[J]. CancerRes, 2003,63(8) :1789-1797.
7RENE F M, RUND P, MICHAEL G. Prognostic significance of type IV collagen and immunoreaetity IV inurothellal carcinoma of the bladder[J].Cancer J, 1990,12:2583-2586.
2Kari Alitalo,Tapani Hovi,Antti Vaheri,et al.Fibronectin is produced by human macrophages[J] . J Exp Med, 1980,151: 602-613.
3Nakayama T, Ohtcur A, Nazuhito K, et al, Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase : a hemologue of the nm23 gene product[J]. J Natl Cancer Inst, 1992,84(17):1349-1352.
4Heweit RE, Pone DG, Griffin NR, et al. Relationships between epithelial membrane staining patterns in primary colorectal carcinomas and the extect of tumor speed[J]. Int J Cancer, 1991,48(6) : 855 - 859.
5Rene FM, Rund P, Michael G. Prognostic significance of type Ⅳ collagen and immunoreactity Ⅳ in urothellal carcinoma of the bladder Cancer[J] . 1990,66(12) :2583 - 2586.
6Yamamoto E, Kohama G, Sunakawa H,et al. Mode of invasion:bleomycin sensitivity and clinicalcourse in squmaous cell carcinoma of the oral cavity[J]. Cancer, 1983,51 (8) :2175-2128.
7Cold I, Davidson B, Leme I-Geva L, et al. Expression of extracellular matrix proteins in cevical squamous cell carcinoma: a clinicopathological study[J]. J Clin Pathol, 1998, 51 (2) :781 -785.
8Ruoslanti E. Fibronectin and its receptors [ J ]. Annu Rev Biochem, 1998, 57(2) :375 -413.
9Nichols R. Bilateral Neck dissection[J]. Am J Surg, 1996, 11(7) :377 -381.
5LIND M,DELEURAN B,THESTRUP-PEDERSEN K,et al.Chemotaxis of human osteoblasts effects of osteotropic growth factors[J].APMS,1995,103(2):140-146.
6COOK S D,SALKELD S L,BRINKER M R,et al.Use of an osteoinductive biomaterial (rhOP-1) in heal large segmental long bone defects[J].J Orauma,1998,12(6):407-412.
7Hicks WL Jr, Loree TR, Garcia RI, et al. Squamous cell carcino- ma of the floor of mouth : a 20-year review [ J ]. Head Neck, 1997, 19 ( 5 ) :400-405.
8Meng XN, Jin Y, Yu Y, et al. Charaeterisation of fibroneetin-me- diated FAK signalling pathways in lung cancer cell migration and invasion[ J]. Br J Cancer,2009,101 (2) :327-334.
9Wehmeier M, Petrich T, Brand K, et al. Oncofetal fibronectin mR- NA is highly abundant in the blood of patients with papillary thy- roid carcinoma and correlates with high-serum thyroid-stimulating hormone levels [ J ]. Thyroid, 2010,20 ( 6 ) :607 -613.
10Steffens S,Schrader A J, Vetter G,et al. Fibronectin 1 protein ex- pression in clear cell renal cell carcinoma [ J]. Oncol Lett,2012,3 (4) :787-790.
